As mentioned earlier, most PKM2 in cancer tissues are low-activity dimers, which catalyze relatively less pyruvate production, thus providing sufficient intermediate components for conversion into proteins, nucleotides, and other vital substances necessary for cancer cell proliferation [229]. The gene discussed is PKM; the disease is cancer.